As the World Health Organization approves booster shots for the immunocompromised, the inevitable scramble for acquiring them has already begun. But as always, the wealthy countries are in an advantageous position to secure their needs quicker than others, which is likely to lead to hoarding of Covid-19 booster vaccines, the WHO has preemptively warned.
It is the distressing reality of the world that developing nations always find themselves being left behind because of irresponsible actions by the wealthiest countries. The WHO vaccine director stated in no uncertain terms that there is a risk of the global vaccine supply again reverting to “to high-income countries hoarding vaccine.”
Not only do the developed nations have far superior healthcare infrastructure to support their citizens in case of new spikes from the dreaded Omicron variant, but they also do not need to deplete the global supply because new drugs are now available that demonstrably boost treatment efficacy, taking out a lot of the unknowables from the Covid-19 puzzle.
By contrast, developing countries will benefit from inoculating the most vulnerable population for whom adequate emergency medical services simply don’t exist in developing countries.
Although the rich countries donate a lot of vaccines to the poorer nations, the WHO vaccine director, however, pointed out that a major problem for Covax had been wealthy countries donating vaccines with a relatively short shelf life.
Any hoarding of vaccines will have a cascading effect across the world, and it will be definitely harshest on developing countries. Bangladesh in particular has dealt with vaccine shortage in the past and is still some way away from complete vaccination.
The government should focus its diplomatic efforts to pressure the international community to act against vaccine hoarding. But the responsibility ultimately lies with the wealthy countries, who should not ignore WHO’s warning.